DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

AVANIR PHARMACEUTICALS (NASDAQ: AVNR)



company name or ticker

Why Avanir Pharmaceuticals, Pepco, and Level 3 Communications Are Today's 3 Best Stocks

A sea of U.S. economic data and an FOMC meeting send the S&P 500 near an all-time record close as Avanir Pharmaceuticals, Pepco Holdings, and Level 3 Communications soar.

Salvation for Avanir in Patent Exclusivity

Why Avanir Pharmaceuticals (AVNR) Stock Spiked Today

Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System (CNS) Therapeutics Fran

Avanir Pharmaceuticals Announces Data Presentation of Central Nervous System (CNS) Therapeutics Franchise at American Academy of Neurology Meeting

Avanir's AVP-825 under FDA Review - Analyst Blog

Morning Market Movers

UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acut

UPDATE: Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine

Avanir Provides New Data - Analyst Blog

Avanir Provides New Data - Analyst Blog

Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

Notable Two Hundred Day Moving Average Cross - AVNR

See More Articles...